Status:
COMPLETED
Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine (QIV) in Children Previously Vaccinated in Trial V118_05
Lead Sponsor:
Seqirus
Conditions:
Influenza
Eligibility:
All Genders
12-84 years
Phase:
PHASE3
Brief Summary
Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine Compared to Non-Adjuvanted Comparator Influenza Vaccine in Children Previously Vaccinated in Trial V118\_05
Eligibility Criteria
Inclusion
- Male or female subject who has completed their Day 181 clinic visit for non-naïve subjects or their Day 209 clinic visit for naïve subjects in parent study.
- Individuals who give written informed consent, who can comply with study procedures, and who are available for follow-up
Exclusion
- Individuals recently vaccinated against influenza.
- Subjects with contraindications to receive influenza vaccine.
- Please contact the site for additional eligibility criteria.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
607 Patients enrolled
Trial Details
Trial ID
NCT02255409
Start Date
October 1 2014
End Date
January 1 2016
Last Update
March 15 2023
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego, California, United States, 92103
2
San Gabriel, California, United States, 91706
3
Colorado Springs, Colorado, United States, 80920
4
Melbourne, Florida, United States, 32935